Cargando…

A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation

Antiretroviral therapy (ART) suppresses viral replication in people living with HIV. Yet, infected cells persist for decades on ART and viremia returns if ART is stopped. Persistence has been attributed to viral replication in an ART sanctuary and long-lived and/or proliferating latently infected ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reeves, Daniel B., Duke, Elizabeth R., Wagner, Thor A., Palmer, Sarah E., Spivak, Adam M., Schiffer, Joshua T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240116/ https://www.ncbi.nlm.nih.gov/pubmed/30446650 http://dx.doi.org/10.1038/s41467-018-06843-5

Ejemplares similares

Anti-proliferative therapy for HIV cure: a compound interest approach
por: Reeves, Daniel B., et al.
Publicado: (2017)

Substantial uneven proliferation of CD4(+) T cells during recovery from acute HIV infection is sufficient to explain the observed expanded clones in the HIV reservoir
por: Tettamanti Boshier, Florencia A., et al.
Publicado: (2022)

Persistent HIV-1 replication during antiretroviral therapy
por: Martinez-Picado, Javier, et al.
Publicado: (2016)

Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence
por: Reeves, Daniel B., et al.
Publicado: (2023)

Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
por: Sun, Weiwei, et al.
Publicado: (2023)

Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
por: Sun, Weiwei, et al.
Publicado: (2023)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

Associations of HIV persistence, cigarette smoking, inflammation, and pulmonary dysfunction in people with HIV on antiretroviral therapy
por: Cyktor, Joshua, et al.
Publicado: (2022)

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
por: Gandhi, Rajesh T., et al.
Publicado: (2017)

The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy
por: Calmy, Alexandra, et al.
Publicado: (2018)

Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy
por: Lee, Eunok, et al.
Publicado: (2019)

HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
por: Kulpa, Deanna A, et al.
Publicado: (2015)

Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
por: Martin, Genevieve E., et al.
Publicado: (2021)

Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
por: Ahmed, Duale, et al.
Publicado: (2018)

Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy
por: Jacobs, Jana L., et al.
Publicado: (2020)

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
por: Zerbato, Jennifer M., et al.
Publicado: (2022)

Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
por: Chiu, Chris Y., et al.
Publicado: (2023)

Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy
por: Tang, Yuyang, et al.
Publicado: (2023)

Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy
por: Singh, Kanal, et al.
Publicado: (2023)

HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence
por: Maldarelli, Frank
Publicado: (2015)

HIV persistence in tissue macrophages of humanized myeloid only mice during antiretroviral therapy
por: Honeycutt, J. B., et al.
Publicado: (2017)

Human Immunodeficiency Virus (HIV)–Infected CCR6(+) Rectal CD4(+) T Cells and HIV Persistence On Antiretroviral Therapy
por: Anderson, Jenny L, et al.
Publicado: (2020)

1036. Persistence of Guideline-Recommended Antiretroviral Therapy Regimens among Persons Living with HIV Newly Initiating Treatment in the US
por: Cohen, Joshua P, et al.
Publicado: (2020)

H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir
por: Wagner, Thor A., et al.
Publicado: (2017)

Small-for-Gestational-Age Births in Pregnant Women with HIV, due to Severity of HIV Disease, Not Antiretroviral Therapy
por: Aaron, Erika, et al.
Publicado: (2012)

Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy
por: Lee, Sulggi A., et al.
Publicado: (2016)

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
por: Anderson, Elizabeth M., et al.
Publicado: (2020)

Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy
por: Bhatti, Adnan Bashir, et al.
Publicado: (2016)

Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy
por: Peltenburg, N. Chantal, et al.
Publicado: (2018)

The Persistence of HIV Diversity, Transcription, and Nef Protein in Kaposi’s Sarcoma Tumors during Antiretroviral Therapy
por: Nolan, David J., et al.
Publicado: (2022)

Persistence of envelopes in different CD4(+) T-cell subsets in antiretroviral therapy-suppressed people with HIV
por: Gartner, Matthew J., et al.
Publicado: (2023)

CD4 T Cell Metabolism Is a Major Contributor of HIV Infectivity and Reservoir Persistence
por: Taylor, Harry E., et al.
Publicado: (2020)

Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy
por: Rönsholt, Frederikke F., et al.
Publicado: (2013)

New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy
por: Wacleche, Vanessa Sue, et al.
Publicado: (2016)

HIV persists in CCR6(+)CD4(+) T cells from colon and blood during antiretroviral therapy
por: Gosselin, Annie, et al.
Publicado: (2017)

Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort study
por: Lewis, Joseph M., et al.
Publicado: (2017)

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study
por: Henrich, Timothy J., et al.
Publicado: (2017)

Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence
por: Darwish, Ilyse, et al.
Publicado: (2021)

HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
por: Mavigner, Maud, et al.
Publicado: (2009)

LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy
por: Planas, Delphine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gn8dhtpp5tsij40afvq79ff70d